DE602005025616D1 - STRONTIUM-CONTAINING COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF NEKROTISING BONE DISEASES - Google Patents

STRONTIUM-CONTAINING COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF NEKROTISING BONE DISEASES

Info

Publication number
DE602005025616D1
DE602005025616D1 DE602005025616T DE602005025616T DE602005025616D1 DE 602005025616 D1 DE602005025616 D1 DE 602005025616D1 DE 602005025616 T DE602005025616 T DE 602005025616T DE 602005025616 T DE602005025616 T DE 602005025616T DE 602005025616 D1 DE602005025616 D1 DE 602005025616D1
Authority
DE
Germany
Prior art keywords
nekrotising
strontium
prevention
treatment
containing compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005025616T
Other languages
German (de)
Inventor
Christian Hansen
Henrik Nilsson
Stephan Christgau
Henry G Bone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osteologix AS
Original Assignee
Osteologix AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteologix AS filed Critical Osteologix AS
Priority claimed from PCT/DK2005/000140 external-priority patent/WO2005082385A1/en
Publication of DE602005025616D1 publication Critical patent/DE602005025616D1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
DE602005025616T 2004-02-26 2005-02-28 STRONTIUM-CONTAINING COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF NEKROTISING BONE DISEASES Active DE602005025616D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54852904P 2004-02-26 2004-02-26
DKPA200400313 2004-02-26
PCT/DK2005/000140 WO2005082385A1 (en) 2004-02-26 2005-02-28 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions

Publications (1)

Publication Number Publication Date
DE602005025616D1 true DE602005025616D1 (en) 2011-02-10

Family

ID=34956357

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005025616T Active DE602005025616D1 (en) 2004-02-26 2005-02-28 STRONTIUM-CONTAINING COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF NEKROTISING BONE DISEASES

Country Status (6)

Country Link
JP (1) JP4839302B2 (en)
AT (1) ATE493137T1 (en)
DE (1) DE602005025616D1 (en)
DK (1) DK1732575T3 (en)
PT (1) PT1732575E (en)
SI (1) SI1732575T1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809286C (en) * 2009-09-11 2018-02-13 Straxcorp Pty Ltd Method and system for image analysis of selected tissue structures

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737471A3 (en) * 1995-04-10 2000-12-06 L'oreal Use of alkaline earth metal salts as TNF-alpha inhibitor in a topical composition and composition obtained therefrom
CA2441538A1 (en) * 2001-03-22 2002-10-17 Barnes-Jewish Hospital Stimulation of osteogenesis using rank ligand fusion proteins
NO20014746D0 (en) * 2001-09-28 2001-09-28 Clas M Kjoelberg Pain reliever
WO2003041717A1 (en) * 2001-11-12 2003-05-22 Ono Pharmaceutical Co., Ltd. Persistent filmy preparation for topical administration containing prostaglandin derivative

Also Published As

Publication number Publication date
PT1732575E (en) 2011-03-23
JP4839302B2 (en) 2011-12-21
JP2007523916A (en) 2007-08-23
DK1732575T3 (en) 2011-03-28
SI1732575T1 (en) 2011-05-31
ATE493137T1 (en) 2011-01-15

Similar Documents

Publication Publication Date Title
ATE395871T1 (en) INTEGRAL NAIL FOR THE TREATMENT OF PROXIMAL FEMUR Fractures
ATE446754T1 (en) COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA AND/OR GLUCO-REGULATORY DISORDERS
ATE512663T1 (en) COMBINATION FOR THE TREATMENT OF CELL PROLIFERATION DISEASES
DE502005010499D1 (en) Implant for the treatment of obesity
DE602005021970D1 (en) USE OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF PAIN BY BONE CANCER, CHEMOTHERAPY AND NUCLEOSIDE-RELATED PAIN
ATE440866T1 (en) NOGO-A-NEUTRALIZING IMMUNOLOBULINES FOR THE TREATMENT OF NEUROLOGICAL DISEASES
DE602005007717D1 (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
DE602006018583D1 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF PERIPHERAL VASCULAR DISEASES
ATE447551T1 (en) BIPHENYLOXYACETIC ACID - DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
DE602006019838D1 (en) PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE FOR THE TREATMENT OF MENTAL DISEASES
DE602007011908D1 (en) USE OF GPR119 RECEPTORAGONISTS FOR INCREASING THE BONE MASS AND TREATING OSTEOPOROSIS AND COMBINATION THERAPY THEREOF
DE60324777D1 (en) USE OF IL-18 INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF PERIPHERAL VASCULAR DISEASES
DE602005014145D1 (en) MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
PL1732575T3 (en) Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
DE602007011906D1 (en) TETRAHYDROPYRIDOTHIA PYRIMIDINE COMPOUNDS AND USE FOR THE TREATMENT OF PROLIFERATIVE DISEASES
DE602006009899D1 (en) USE OF OXYCODONE FOR THE TREATMENT OF VISCERAL PAIN
DE502006007982D1 (en) NEW MEDICINE COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
ATE443704T1 (en) PYRIDOPYRIMIDINONE FOR THE TREATMENT OF CANCER DISEASES
DE602005014141D1 (en) MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
DE602005016141D1 (en) S-MIRTAZAPINE FOR THE TREATMENT OF HITZEWALLUNGEN
DE602004019576D1 (en) FOR THE TREATMENT OF PAIN PIPERAZINE
DE60224004D1 (en) USE OF IL-18 INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF HEART DISEASES
DE602005015434D1 (en) MEANS FOR THE TREATMENT OF PSYCHONEUROTIC DISEASES
ATE346597T1 (en) CARBAMATE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISEASES
ATE482707T1 (en) 1-Ä2H-1-BENZOPYRAN-2-ON-8-YLÜ-PIPERAZINE DERIVATIVES FOR THE TREATMENT OF PAIN